# A Phase I Clinical Trial to Evaluate LIT-00814 Tablets in Patients With Advanced Solid Tumor

> **NCT06205082** · PHASE1 · ENROLLING_BY_INVITATION · sponsor: **LittDD Medicines Ltd** · enrollment: 81 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** LIT-00814

## Key facts

- **NCT ID:** NCT06205082
- **Lead sponsor:** LittDD Medicines Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-10-14
- **Primary completion:** 2025-10-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 81 (ESTIMATED)
- **Last updated:** 2024-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06205082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06205082, "A Phase I Clinical Trial to Evaluate LIT-00814 Tablets in Patients With Advanced Solid Tumor". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06205082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*